September 25, 2007 – Medical device maker MEDRAD INC. has partnered with the National Prostate Cancer Coalition (NPCC) to provide information about prostate MR imaging to thousands of men who participate in NPCC’s free mobile screening program.

MEDRAD markets an endorectal coil for use in prostate MR that provides pictures of the prostate to assist physicians in diagnosing and staging cancer and planning treatment options. MEDRAD will contribute educational materials about prostate MR, including animation demonstrating the procedure, physician interviews, medical images, a list of hospitals offering the procedure and other information.

Prostate cancer is a growing problem for American men with estimates that one of every six men will get prostate cancer in their lifetime. In addition to offering free prostate cancer screenings with the Drive Against Prostate Cancer mobile screening program, NPCC offers men and their families prostate cancer information and resources through their Website and weekly electronic newsletter, AWARE.

For more information: www.fightprostatecancer.org and www.medrad.com


Additional Content

News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
News | Radiation Oncology

Jan. 8, 2026 — RefleXion Medical, an external-beam theranostic oncology company, has announced the U.S. Food and Drug ...

Time January 13, 2026
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
News | Imaging Software Development

June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...

Time June 12, 2025
arrow
News | Artificial Intelligence

September 7, 2023 — Paige, a provider of end-to-end digital pathology solutions and clinical AI, has announced a ...

Time September 07, 2023
arrow
Subscribe Now